Clinical Study
Diabetes and Hypertension among Patients Receiving Antiretroviral Treatment Since 1998 in Senegal: Prevalence and Associated Factors
Table 2
Main ARV drugs used and mean duration of exposure since ART initiation.
| | Type of ARV drug* | Number of patients exposed | Mean duration | | (months) (±SD) |
| | Any ARV | 242 | 110 | (±13) | | Zidovudine (AZT) | 173 | 52 | (±45) | | Stavudine (d4T) | 103 | 23 | (±33) | | Didanosine (ddI) | 156 | 50 | (±48) | | Lamivudine (3TC) | 240 | 88 | (±32) | | Efavirenz (EFV) | 182 | 55 | (±44) | | Nevirapine (NVP) | 77 | 22 | (±47) | | Indinavir (IDV) | 107 | 25 | (±33) | | Lopinavir/ritonavir (LPV/r) | 61 | 7 | (±15) |
|
|
Abacavir, nelfinavir, and tenofovir were used by a few patients with very short durations of exposure.
|
